RANI Average Annual Return Since 2021
Growth of $10,000.00
Without Dividends Reinvested Into RANI


Also see:
RANI stock yearly return 2022
RANI stock yearly return 2023
RANI YTD return
Compare RANI average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return
Start date: 08/02/2021
End date: 06/24/2024
Start price/share: $10.75
End price/share: $4.11
Dividends collected/share: $0.00
Total return: -61.77%
RANI Average Annual Return: -28.25%
Starting investment: $10,000.00
Ending investment: $3,823.63
Years: 2.90


RANI average annual return is presented with the assumption of reinvestments of any dividends on ex-date.
Rani Therapeutics Holdings is a clinical stage biotherapeutics company advancing technologies to enable the development of orally administered biologics. Co. has developed the RaniPill capsule, which is its novel, proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The RaniPill capsule is an orally ingestible pill approximately the size of a “000” capsule (or similar to the size of a standard fish oil or calcium pill) that is designed to automatically administer a precise therapeutic dose of medication upon deployment in the small intestine. The RANI average annual return since 2021 is shown above.

The Average Annual Return on the RANI average annual return since 2021 page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends.

Thus, researching Average Annual Returns is good practice for investors — whether RANI average annual return since 2021 or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the RANI average annual return calculation with any dividends reinvested as applicable (on ex-dates).
Quotes delayed 20 minutes

Email EnvelopeFree RANI Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Don't Forget Dividends in Average Annual Return!


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Rani Therapeutics Holdings (RANI) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

RAPT Average Annual Return
RARE Average Annual Return
RBOT Average Annual Return
RCEL Average Annual Return
RCKT Average Annual Return
RCUS Average Annual Return
RDHL Average Annual Return
RDNT Average Annual Return
RDY Average Annual Return
REGN Average Annual Return
More Healthcare companies »

 

RANI Average Annual Return Since 2021 | www.AverageAnnualReturn.com | Copyright © 2021 - 2024, All Rights Reserved

Nothing in AverageAnnualReturn.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.